Focus Fund
Now Open for Investment
The Focus Fund is cultivate(MD)’s fifth fund and is built to identify, support, and exit best-in-class early-stage medical device companies by 2031.
Focus Fund Investment Criteria
Every company in the Focus Fund must meet a rigorous set of criteria. Technology alone is never enough. There has to be a clear clinical rationale, a viable market path, and a strong team capable of executing.
Significant Unmet Need
The device must address a real gap in patient care, not just an incremental improvement on what already exists.
Workflow Compatibility
Solutions must integrate into existing clinical workflows. We don't bet on behavioral change alone.
Clear Reimbursement Path
We require established or readily achievable reimbursement pathways, not speculative CPT code petitions.
Defined FDA Strategy
For non-cleared devices, we scrutinize the regulatory roadmap closely to ensure it's realistic and well-resourced.
Strong Team
We evaluate the full team, from the C-suite to engineers to the broader investor syndicate behind the company.
Exit by 2031
Every company must have a credible path to a liquidity event within the fund's defined timeline.
Interested in learning more?
Please feel free to complete the form below, and someone from our team will be in touch with you shortly.
"*" indicates required fields
This page is intended for informational purposes only.
